Focus on the field of biopharmaceutical intellectual securities products landing Pingshan.

Pharmaceutical Network Industry Dynamics: The biopharmaceutical industry is a technology-intensive industry, and its development can not be separated from the protection of intellectual property rightsOn July 16th, the first branch of the country focused on the specialized field of biomedicine intellectual property securitization products officially landed in Pingshan District, ShenzhenShenzhen in the intellectual property financial innovation, initially formed a strong innovative, feasible, exemplary product systemThis year, China issued "on deepening the reform of institutional mechanisms to speed up the implementation of innovation-driven development strategy", clearly put forward to explore the development of intellectual property securitization business, in this series of intensive policy dividends, to promote the development of intellectual property securitizationIt is reported that, in the face of the new situation of intellectual property work, new tasks, new requirements, the Shenzhen Municipal Market Supervision Administration as the competent department of intellectual property rights, the full deployment to promote the securitization of intellectual property rights in ShenzhenPingshan Is the innovation highland of Shenzhen, but also the strong intellectual property area with outstanding industrial characteristics, which has significant advantages in exploring and carrying out the pilot work of securitization of intellectual property rightsThe landing of this product highlights the scientific and technological innovation strength of Pingshan biopharmaceutical industry, which is of great significance to promote the high-quality development of Shenzhen biopharmaceutical industryAt the same time, it will be conducive to further improve the Pingshan intellectual property service chain, optimize the regional innovation ecological systemAt present, Pingshan has formed a bio-innovation drugs, high-end medical equipment and biotechnology three sub-sectors as the core of the bio-industry cluster, forming a relatively complete industrial chainAmong them, in the field of biomedicine, Pingshan has the first batch of national bio-industry base, in recent years, Pingshan biopharmaceutical industry has developed rapidly, has become one of the three leading industries in Pingshan, currently forming 525 biopharmaceutical enterprises as the main body, a number of high-end research institutions and platforms as the support, to bio-innovation, high-end medical equipment and biotechnology three sub-sectors as the core of the bio-industry clusterAnd each year more than 80 new enterprises, the average annual growth of industrial output value of 30%It is worth mentioning that Pingshan's Splendid East Road, this road because of the bio-industry aggregation effect, known as Pingshan's "BT" AvenueOn this "BT" avenue, more than 100 biopharmaceutical companies, including 11 biopharmaceutical listed companies, such as the Shanghai Stock Exchange on August 12, 2019 to ring the opening gong of micro-core biologyThere are also the world's top 500 enterprises Sanofi Pasteur production base, as well as Xinlitai, Hanyu Pharmaceuticals, Libang Instruments, Ericon, BangJian Medical, Da Fu Pharmaceuticals, biological sources, deep-map medicine and other biopharmaceutical listed enterprisesAt the same time, Pingshan also attaches importance to the accumulation of human resources, and constantly increase the introduction of high-level talent at home and abroad, the establishment of a diversified talent ecosystem, to serve different industries, talent gathering effect to drive the vigorous development of the biopharmaceutical industrySince this year, Shenzhen has accelerated the pace of development of the biopharmaceutical industry, the introduction of a series of favorable policies to support the development of the biopharmaceutical industryAmong them, the "Shenzhen City to promote the development of the biopharmaceutical industry," as well as the "Shenzhen Biopharmaceutical Industry Cluster Development Implementation Plan (2020-2025)," "Shenzhen Biopharmaceutical Industry Development Action Plan (2020-2025)" "Shenzhen to promote the development of the biopharmaceutical industry, a number of measures", three supporting documents, put forward the construction of Shenzhen bio-pharmaceutical "one-core multi-center" new pattern Here, the "one core" is to Pingshan biopharmaceutical industry gathering development of the main park as the core, accelerate the construction of Pingshan Biopharmaceutical Science and Technology Industry City